FBRX — Forte Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Forte Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.8	58.8	42	41.1	37.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23	59.9	42.5	41.5	38.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.2	0.097	0	—	0.109
Long Term Notes Receivable
Other Long Term Assets
Total Assets	28.2	61.2	43.3	42	39
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.2	2.26	1.76	3.18	3.67
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.3	2.26	1.76	3.18	3.67
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.8	59	41.5	38.8	35.3
Total Liabilities & Shareholders' Equity	28.2	61.2	43.3	42	39
Total Common Shares Outstanding